Also trades as: ALVO (NASDAQ) · $vol 2M
ALVOW NASDAQ
Alvotech
1W: -20.0%
1M: -39.4%
3M: -47.4%
YTD: -74.4%
1Y: -91.5%
3Y: -69.2%
$0.25
+0.05 (+25.00%)
Weekly Expected Move ±55.1%
$-0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$62.4M
52W Range0.2-1.52
Volume2,725
Avg Volume4,949
Beta0.21
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOLisa Graver
Employees1,012
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-06-16
Websitealvotech.com
Saemundargata 15-19
Luxembourg 102
IS
Luxembourg 102
IS
354 422 4500
About Alvotech
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.
Latest News
Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End
Alvotech (ALVO) Q1 2026 Earnings Transcript
Alvotech Q1 Earnings Call Highlights
Alvotech (ALVO) to Release Quarterly Earnings on Wednesday - MarketBeat
Alvotech (NASDAQ:ALVO) Receives Consensus Recommendation of “Hold” from Brokerages
Recent Insider Trades
No insider trades found